Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection

PLoS Pathogens

Volumn 14, Issue 1, 2018, Pages

  Alandijany, Thamir ^a,b   Roberts, Ashley P E ^a   Conn, Kristen L ^a,c   Loney, Colin ^a   McFarlane, Steven ^a   Orr, Anne ^a   Boutell, Chris ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DNA POLYMERASE; EDOXUDINE; INTERFERON GAMMA INDUCIBLE PROTEIN 16; JANUS KINASE; LENTIVIRUS VECTOR; PHOSPHONOACETIC ACID; PROMYELOCYTIC LEUKEMIA PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; IFI16 PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PML PROTEIN, HUMAN; RNA DIRECTED DNA POLYMERASE INHIBITOR; UBIQUITIN PROTEIN LIGASE; VIRAL PROTEIN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; HERPES SIMPLEX; HOST RESISTANCE; HUMAN; HUMAN ALPHAHERPESVIRUS 1; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; VIRAL PLAQUE ASSAY; VIRUS ENTRY; VIRUS GENOME; VIRUS LOAD; VIRUS RELEASE; VIRUS REPLICATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL LINE; CLICK CHEMISTRY; DRUG EFFECT; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; KINETICS; LYSOGENIZATION; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TRANSFORMED CELL LINE; VIROLOGY; VIRUS INCLUSION;

CELL LINE; CELL LINE, TRANSFORMED; CELLS, CULTURED; CLICK CHEMISTRY; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INCLUSION BODIES, VIRAL; KINETICS; LYSOGENY; MUTATION; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMYELOCYTIC LEUKEMIA PROTEIN; REVERSE TRANSCRIPTASE INHIBITORS; RNA INTERFERENCE; UBIQUITIN-PROTEIN LIGASES; VIRAL PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 85041661903     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006769     Document Type: Article

References (95)

1. Komatsu T, Nagata K, Wodrich H, The Role of Nuclear Antiviral Factors against Invading DNA Viruses: The Immediate Fate of Incoming Viral Genomes. Viruses. 2016;8(10). doi: 10.3390/v8100290 27782081; PubMed Central PMCID: PMCPMC5086622.
2. Yan N, Chen ZJ, Intrinsic antiviral immunity. Nat Immunol. 2012;13(3):214–22. doi: 10.1038/ni.2229 22344284; PubMed Central PMCID: PMCPMC3549670.
3. Blanco-Melo D, Venkatesh S, Bieniasz PD, Intrinsic cellular defenses against human immunodeficiency viruses. Immunity. 2012;37(3):399–411. Epub 2012/09/25. doi: 10.1016/j.immuni.2012.08.013 [pii]. 22999946.
4. Diner BA, Lum KK, Cristea IM, The emerging role of nuclear viral DNA sensors. J Biol Chem. 2015;290(44):26412–21. doi: 10.1074/jbc.R115.652289 26354430; PubMed Central PMCID: PMCPMC4646299.
5. Knipe DM, Nuclear sensing of viral DNA, epigenetic regulation of herpes simplex virus infection, and innate immunity. Virology. 2015;479–480:153–9. doi: 10.1016/j.virol.2015.02.009 25742715; PubMed Central PMCID: PMCPMC4424148.
6. Dempsey A, Bowie AG, Innate immune recognition of DNA: A recent history. Virology. 2015;479–480:146–52. doi: 10.1016/j.virol.2015.03.013 25816762; PubMed Central PMCID: PMCPMC4424081.
7. Everett RD, The spatial organization of DNA virus genomes in the nucleus. PLoS Pathog. 2013;9(6):e1003386. doi: 10.1371/journal.ppat.1003386 23825941; PubMed Central PMCID: PMCPMC3694854.
8. Maul GG, Ishov AM, Everett RD, Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology. 1996;217(1):67–75. doi: 10.1006/viro.1996.0094 8599237.
9. Everett RD, Sourvinos G, Leiper C, Clements JB, Orr A, Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. J Virol. 2004;78(4):1903–17. Epub 2004/01/30. doi: 10.1128/JVI.78.4.1903-1917.2004 14747555; PubMed Central PMCID: PMC369473.
10. Everett RD, Murray J, ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol. 2005;79(8):5078–89. doi: 10.1128/JVI.79.8.5078-5089.2005 15795293; PubMed Central PMCID: PMCPMC1069553.
11. Cuchet-Lourenco D, Anderson G, Sloan E, Orr A, Everett RD, The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection. J Virol. 2013;87(24):13422–32. doi: 10.1128/JVI.02474-13 24089555; PubMed Central PMCID: PMCPMC3838218.
12. Everett RD, Dynamic Response of IFI16 and Promyelocytic Leukemia Nuclear Body Components to Herpes Simplex Virus 1 Infection. J Virol. 2015;90(1):167–79. doi: 10.1128/JVI.02249-15 26468536; PubMed Central PMCID: PMCPMC4702556.
13. Orzalli MH, Broekema NM, Diner BA, Hancks DC, Elde NC, Cristea IM, et al. cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc Natl Acad Sci U S A. 2015;112(14):E1773–81. doi: 10.1073/pnas.1424637112 25831530; PubMed Central PMCID: PMCPMC4394261.
14. Diner BA, Lum KK, Toettcher JE, Cristea IM, Viral DNA Sensors IFI16 and Cyclic GMP-AMP Synthase Possess Distinct Functions in Regulating Viral Gene Expression, Immune Defenses, and Apoptotic Responses during Herpesvirus Infection. MBio. 2016;7(6). doi: 10.1128/mBio.01553-16 27935834; PubMed Central PMCID: PMCPMC5111403.
15. Lilley CE, Chaurushiya MS, Boutell C, Everett RD, Weitzman MD, The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathog. 2011;7(6):e1002084. doi: 10.1371/journal.ppat.1002084 21698222; PubMed Central PMCID: PMCPMC3116817.
16. Cuchet-Lourenco D, Boutell C, Lukashchuk V, Grant K, Sykes A, Murray J, et al. SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog. 2011;7(7):e1002123. doi: 10.1371/journal.ppat.1002123 21779164; PubMed Central PMCID: PMCPMC3136452.
17. Boutell C, Cuchet-Lourenco D, Vanni E, Orr A, Glass M, McFarlane S, et al. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 2011;7(9):e1002245. doi: 10.1371/journal.ppat.1002245 21949651; PubMed Central PMCID: PMCPMC3174244.
18. Conn KL, Wasson P, McFarlane S, Tong L, Brown JR, Grant KG, et al. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response. J Virol. 2016;90(9):4807–26. doi: 10.1128/JVI.03055-15 26937035; PubMed Central PMCID: PMCPMC4836348.
19. Brown JR, Conn KL, Wasson P, Charman M, Tong L, Grant K, et al. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1. J Virol. 2016;90(13):5939–52. doi: 10.1128/JVI.00426-16 27099310; PubMed Central PMCID: PMCPMC4907222.
20. Everett RD, Chelbi-Alix MK, PML and PML nuclear bodies: implications in antiviral defence. Biochimie. 2007;89(6–7):819–30. doi: 10.1016/j.biochi.2007.01.004 17343971.
21. Geoffroy MC, Chelbi-Alix MK, Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res. 2011;31(1):145–58. Epub 2011/01/05. doi: 10.1089/jir.2010.0111 21198351.
22. Everett RD, Maul GG, HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 1994;13(21):5062–9. 7957072; PubMed Central PMCID: PMCPMC395452.
23. Boutell C, Sadis S, Everett RD, Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol. 2002;76(2):841–50. doi: 10.1128/JVI.76.2.841-850.2002 11752173; PubMed Central PMCID: PMCPMC136846.
24. Vanni E, Gatherer D, Tong L, Everett RD, Boutell C, Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a). J Virol. 2012;86(11):6323–33. doi: 10.1128/JVI.07210-11 22438555; PubMed Central PMCID: PMCPMC3372195.
25. Chelbi-Alix MK, de The H, Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene. 1999;18(4):935–41. Epub 1999/02/19. doi: 10.1038/sj.onc.1202366 10023669.
26. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M, et al. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol. 1998;72(8):6581–91. 9658103.
27. Muller S, Matunis MJ, Dejean A, Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. Embo J. 1998;17(1):61–70. doi: 10.1093/emboj/17.1.61 9427741.
28. Johnson KE, Chikoti L, Chandran B, Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol. 2013;87(9):5005–18. doi: 10.1128/JVI.00082-13 23427152; PubMed Central PMCID: PMCPMC3624293.
29. Orzalli MH, DeLuca NA, Knipe DM, Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A. 2012;109(44):E3008–17. doi: 10.1073/pnas.1211302109 23027953; PubMed Central PMCID: PMCPMC3497734.
30. Orzalli MH, Broekema NM, Knipe DM, Relative Contributions of Herpes Simplex Virus 1 ICP0 and vhs to Loss of Cellular IFI16 Vary in Different Human Cell Types. J Virol. 2016;90(18):8351–9. doi: 10.1128/JVI.00939-16 27412599; PubMed Central PMCID: PMCPMC5008076.
31. Diner BA, Lum KK, Javitt A, Cristea IM, Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression. Mol Cell Proteomics. 2015;14(9):2341–56. doi: 10.1074/mcp.M114.047068 25693804; PubMed Central PMCID: PMCPMC4563720.
32. Boutell C, Everett RD, Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J Gen Virol. 2013;94(Pt 3):465–81. doi: 10.1099/vir.0.048900-0 23239572.
33. Stow ND, Stow EC, Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol. 1986;67 (Pt 12):2571–85. doi: 10.1099/0022-1317-67-12-2571 3025339.
34. Yao F, Schaffer PA, An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol. 1995;69(10):6249–58. 7666525; PubMed Central PMCID: PMCPMC189522.
35. Everett RD, Boutell C, Orr A, Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J Virol. 2004;78(4):1763–74. doi: 10.1128/JVI.78.4.1763-1774.2004 14747541; PubMed Central PMCID: PMCPMC369471.
36. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW, Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med. 1999;189(4):663–72. 9989981; PubMed Central PMCID: PMCPMC2192939.
37. Mossman KL, Saffran HA, Smiley JR, Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol. 2000;74(4):2052–6. 10644380; PubMed Central PMCID: PMC111685.
38. Harle P, Sainz B, Jr.Carr DJ, Halford WP, The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology. 2002;293(2):295–304. doi: 10.1006/viro.2001.1280 11886249.
39. Everett RD, The use of fluorescence microscopy to study the association between herpesviruses and intrinsic resistance factors. Viruses. 2011;3(12):2412–24. doi: 10.3390/v3122412 22355446; PubMed Central PMCID: PMCPMC3280513.
40. Everett RD, Sourvinos G, Orr A, Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. J Virol. 2003;77(6):3680–9. doi: 10.1128/JVI.77.6.3680-3689.2003 12610143; PubMed Central PMCID: PMCPMC149519.
41. Catez F, Rousseau A, Labetoulle M, Lomonte P, Detection of the genome and transcripts of a persistent DNA virus in neuronal tissues by fluorescent in situ hybridization combined with immunostaining. J Vis Exp. 2014;(83):e51091. doi: 10.3791/51091 24514006; PubMed Central PMCID: PMCPMC4089569.
42. Wang IH, Suomalainen M, Andriasyan V, Kilcher S, Mercer J, Neef A, et al. Tracking viral genomes in host cells at single-molecule resolution. Cell Host Microbe. 2013;14(4):468–80. doi: 10.1016/j.chom.2013.09.004 24139403.
43. Dembowski JA, DeLuca NA, Selective recruitment of nuclear factors to productively replicating herpes simplex virus genomes. PLoS Pathog. 2015;11(5):e1004939. doi: 10.1371/journal.ppat.1004939 26018390; PubMed Central PMCID: PMCPMC4446364.
44. Dembowski JA, Dremel SE, DeLuca NA, Replication-Coupled Recruitment of Viral and Cellular Factors to Herpes Simplex Virus Type 1 Replication Forks for the Maintenance and Expression of Viral Genomes. PLoS Pathog. 2017;13(1):e1006166. doi: 10.1371/journal.ppat.1006166 28095497; PubMed Central PMCID: PMCPMC5271410.
45. Schmidt N, Hennig T, Serwa RA, Marchetti M, O'Hare P, Remote Activation of Host Cell DNA Synthesis in Uninfected Cells Signaled by Infected Cells in Advance of Virus Transmission. J Virol. 2015;89(21):11107–15. doi: 10.1128/JVI.01950-15 26311877; PubMed Central PMCID: PMCPMC4621119.
46. Johnson KE, Bottero V, Flaherty S, Dutta S, Singh VV, Chandran B, IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications. PLoS Pathog. 2014;10(11):e1004503. doi: 10.1371/journal.ppat.1004503 25375629; PubMed Central PMCID: PMCPMC4223080.
47. Newcomb WW, Brown JC, Induced extrusion of DNA from the capsid of herpes simplex virus type 1. J Virol. 1994;68(1):433–40. 8254753; PubMed Central PMCID: PMCPMC236303.
48. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 1999;147(2):221–34. 10525530; PubMed Central PMCID: PMCPMC2174231.
49. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A, PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol. 2006;80(16):7995–8005. doi: 10.1128/JVI.00734-06 16873256; PubMed Central PMCID: PMCPMC1563828.
50. Everett RD, Parada C, Gripon P, Sirma H, Orr A, Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol. 2008;82(6):2661–72. doi: 10.1128/JVI.02308-07 18160441; PubMed Central PMCID: PMCPMC2258993.
51. Horisberger MA, McMaster GK, Zeller H, Wathelet MG, Dellis J, Content J, Cloning and sequence analyses of cDNAs for interferon- and virus-induced human Mx proteins reveal that they contain putative guanine nucleotide-binding sites: functional study of the corresponding gene promoter. J Virol. 1990;64(3):1171–81. 2154602; PubMed Central PMCID: PMCPMC249231.
52. Haronikova L, Coufal J, Kejnovska I, Jagelska EB, Fojta M, Dvorakova P, et al. IFI16 Preferentially Binds to DNA with Quadruplex Structure and Enhances DNA Quadruplex Formation. PLoS One. 2016;11(6):e0157156. doi: 10.1371/journal.pone.0157156 27280708; PubMed Central PMCID: PMCPMC4900677.
53. Honess RW, Watson DH, Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol. 1977;21(2):584–600. 189089; PubMed Central PMCID: PMCPMC353861.
54. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ, Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977;74(12):5716–20. 202961; PubMed Central PMCID: PMCPMC431864.
55. Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ, Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother. 1979;15(5):642–5. 230783; PubMed Central PMCID: PMCPMC352730.
56. Reardon JE, Spector T, Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J Biol Chem. 1989;264(13):7405–11. 2540193.
57. Artusi S, Perrone R, Lago S, Raffa P, Di Iorio E, Palu G, et al. Visualization of DNA G-quadruplexes in herpes simplex virus 1-infected cells. Nucleic Acids Res. 2016;44(21):10343–53. doi: 10.1093/nar/gkw968 27794039; PubMed Central PMCID: PMCPMC5137459.
58. Mesa RA, Ruxolitinib, a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis. IDrugs. 2010;13(6):394–403. 20506062.
59. Quintas-Cardama A, Vaddi K, Liu P, Manshouri T, Li J, Scherle PA, et al. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood. 2010;115(15):3109–17. doi: 10.1182/blood-2009-04-214957 20130243; PubMed Central PMCID: PMCPMC3953826.
60. Villarino AV, Kanno Y, Ferdinand JR, O'Shea JJ, Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol. 2015;194(1):21–7. doi: 10.4049/jimmunol.1401867 25527793; PubMed Central PMCID: PMCPMC4524500.
61. Everett RD, Young DF, Randall RE, Orr A, STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J Virol. 2008;82(17):8871–81. doi: 10.1128/JVI.00613-08 18579584; PubMed Central PMCID: PMC2519674.
62. Deschamps T, Kalamvoki M, Impaired STING Pathway in Human Osteosarcoma U2OS Cells Contributes to the Growth of ICP0-Null Mutant Herpes Simplex Virus. J Virol. 2017;91(9). doi: 10.1128/JVI.00006-17 28179534; PubMed Central PMCID: PMCPMC5391473.
63. Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 2012;8(7):e1002772. doi: 10.1371/journal.pgen.1002772 22829774; PubMed Central PMCID: PMCPMC3400581.
64. McFarlane S, Preston CM, Human cytomegalovirus immediate early gene expression in the osteosarcoma line U2OS is repressed by the cell protein ATRX. Virus Res. 2011;157(1):47–53. doi: 10.1016/j.virusres.2011.02.002 21310198.
65. Lukashchuk V, McFarlane S, Everett RD, Preston CM, Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol. 2008;82(24):12543–54. doi: 10.1128/JVI.01215-08 18922870; PubMed Central PMCID: PMCPMC2593304.
66. Lukashchuk V, Everett RD, Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J Virol. 2010;84(8):4026–40. doi: 10.1128/JVI.02597-09 20147399; PubMed Central PMCID: PMCPMC2849514.
67. Weller SK, Coen DM, Herpes simplex viruses: mechanisms of DNA replication. Cold Spring Harb Perspect Biol. 2012;4(9):a013011. doi: 10.1101/cshperspect.a013011 22952399; PubMed Central PMCID: PMCPMC3428768.
68. Everett RD, Boutell C, Hale BG, Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol. 2013;11(6):400–11. doi: 10.1038/nrmicro3015 23624814.
69. Glass M, Everett RD, Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol. 2013;87(4):2174–85. doi: 10.1128/JVI.02950-12 23221561; PubMed Central PMCID: PMCPMC3571464.
70. Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A. 2003;100(19):10635–40. doi: 10.1073/pnas.1937626100 12953102; PubMed Central PMCID: PMCPMC196856.
71. Catez F, Picard C, Held K, Gross S, Rousseau A, Theil D, et al. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons. PLoS Pathog. 2012;8(8):e1002852. Epub 2012/08/23. doi: 10.1371/journal.ppat.1002852 [pii]. 22912575; PubMed Central PMCID: PMC3415458.
72. Maroui MA, Calle A, Cohen C, Streichenberger N, Texier P, Takissian J, et al. Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment. PLoS Pathog. 2016;12(9):e1005834. doi: 10.1371/journal.ppat.1005834 27618691; PubMed Central PMCID: PMCPMC5019400.
73. Everett RD, Murray J, Orr A, Preston CM, Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J Virol. 2007;81(20):10991–1004. doi: 10.1128/JVI.00705-07 17670833.
74. Cuchet-Lourenco D, Vanni E, Glass M, Orr A, Everett RD, Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J Virol. 2012;86(20):11209–22. Epub 2012/08/10. doi: JVI.01145-12 [pii] doi: 10.1128/JVI.01145-12 22875967; PubMed Central PMCID: PMC3457127.
75. Everett RD, Boutell C, Pheasant K, Cuchet-Lourenco D, Orr A, Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection. J Virol. 2014;88(5):2763–74. doi: 10.1128/JVI.03417-13 24352468; PubMed Central PMCID: PMCPMC3958091.
76. Everett RD, Boutell C, McNair C, Grant L, Orr A, Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins. J Virol. 2010;84(7):3476–87. doi: 10.1128/JVI.02544-09 20106921; PubMed Central PMCID: PMCPMC2838103.
77. Everett RD, Bell AJ, Lu Y, Orr A, The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71. J Virol. 2013;87(2):978–90. doi: 10.1128/JVI.01103-12 23135716; PubMed Central PMCID: PMCPMC3554063.
78. Lu Y, Everett RD, Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1. J Virol. 2015;89(6):3062–75. doi: 10.1128/JVI.03480-14 25552717; PubMed Central PMCID: PMCPMC4337537.
79. Lu Y, Orr A, Everett RD, Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1. J Virol. 2016;90(21):9664–73. doi: 10.1128/JVI.01224-16 27535048; PubMed Central PMCID: PMCPMC5068519.
80. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010;11(11):997–1004. doi: 10.1038/ni.1932 20890285; PubMed Central PMCID: PMCPMC3142795.
81. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe. 2011;9(5):363–75. doi: 10.1016/j.chom.2011.04.008 21575908; PubMed Central PMCID: PMCPMC3113467.
82. Ansari MA, Singh VV, Dutta S, Veettil MV, Dutta D, Chikoti L, et al. Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol. 2013;87(15):8606–23. doi: 10.1128/JVI.00805-13 23720728; PubMed Central PMCID: PMCPMC3719826.
83. Gariano GR, Dell'Oste V, Bronzini M, Gatti D, Luganini A, De Andrea M, et al. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog. 2012;8(1):e1002498. doi: 10.1371/journal.ppat.1002498 22291595; PubMed Central PMCID: PMCPMC3266931.
84. Horan KA, Hansen K, Jakobsen MR, Holm CK, Soby S, Unterholzner L, et al. Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol. 2013;190(5):2311–9. doi: 10.4049/jimmunol.1202749 23345332; PubMed Central PMCID: PMCPMC3578088.
85. Stratmann SA, Morrone SR, van Oijen AM, Sohn J, The innate immune sensor IFI16 recognizes foreign DNA in the nucleus by scanning along the duplex. Elife. 2015;4:e11721. doi: 10.7554/eLife.11721 26673078; PubMed Central PMCID: PMCPMC4829420.
86. Jin T, Perry A, Jiang J, Smith P, Curry JA, Unterholzner L, et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity. 2012;36(4):561–71. doi: 10.1016/j.immuni.2012.02.014 22483801; PubMed Central PMCID: PMCPMC3334467.
87. Morrone SR, Wang T, Constantoulakis LM, Hooy RM, Delannoy MJ, Sohn J, Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. Proc Natl Acad Sci U S A. 2014;111(1):E62–71. doi: 10.1073/pnas.1313577111 24367117; PubMed Central PMCID: PMCPMC3890864.
88. Scherer M, Otto V, Stump JD, Klingl S, Muller R, Reuter N, et al. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1–382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses. J Virol. 2015;90(3):1190–205. doi: 10.1128/JVI.01973-15 26559840; PubMed Central PMCID: PMCPMC4719593.
89. El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK, Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog. 2014;10(2):e1003975. doi: 10.1371/journal.ppat.1003975 24586174; PubMed Central PMCID: PMCPMC3937294.
90. Kim YE, Ahn JH, Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog. 2015;11(3):e1004785. doi: 10.1371/journal.ppat.1004785 25812002; PubMed Central PMCID: PMCPMC4374831.
91. Maarifi G, Chelbi-Alix MK, Nisole S, PML control of cytokine signaling. Cytokine Growth Factor Rev. 2014;25(5):551–61. doi: 10.1016/j.cytogfr.2014.04.008 24861946.
92. Everett RD, Cross A, Orr A, A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. Virology. 1993;197(2):751–6. doi: 10.1006/viro.1993.1651 7504367.
93. Showalter SD, Zweig M, Hampar B, Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect Immun. 1981;34(3):684–92. 6277788; PubMed Central PMCID: PMCPMC350925.
94. McClelland DA, Aitken JD, Bhella D, McNab D, Mitchell J, Kelly SM, et al. pH reduction as a trigger for dissociation of herpes simplex virus type 1 scaffolds. J Virol. 2002;76(15):7407–17. doi: 10.1128/JVI.76.15.7407-7417.2002 12097553; PubMed Central PMCID: PMCPMC136365.
95. Roberts AP, Abaitua F, O'Hare P, McNab D, Rixon FJ, Pasdeloup D, Differing roles of inner tegument proteins pUL36 and pUL37 during entry of herpes simplex virus type 1. J Virol. 2009;83(1):105–16. doi: 10.1128/JVI.01032-08 18971278; PubMed Central PMCID: PMCPMC2612316.